Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Carr, A; Grund, B; Neuhaus, J; Schwartz, A; Bernardino, J I; White, D; Badel-Faesen, S; Avihingsanon, A; Ensrud, K; Hoy, J

Carr, A; Grund, B; Neuhaus, J; Schwartz, A; Bernardino, J I; White, D; Badel-Faesen, S; Avihingsanon, A; Ensrud, K; Hoy, J.

Affiliation

Carr A; Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia.

HIV Med ; 16 Suppl 1: 137-46, 2015 Apr.

Article in En | MEDLINE | ID: mdl-25711332

Subject(s)

HIV Infections/complications; HIV Infections/pathology; Osteoporosis/diagnosis; Osteoporosis/epidemiology; Absorptiometry, Photon; Adult; Bone Density; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; HIV Infections/immunology; Hip/physiology; Humans; Lumbosacral Region/physiology; Male; Middle Aged; Prevalence; Risk Factors; Spine/physiology

Key words

ART-naïve; HIV; antiretroviral therapy; bone mineral density

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Osteoporosis / HIV Infections Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: HIV Med Year: 2015 Document type: Article

Fulltext

XML

PubMed Links

Search on Google